l-glutamic acid Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central PubChem

Active Ingredient History

NOW
  • Now
Glutamic acid is a non-essential aminoacid used in biosynthesis of proteins. Besides being a building block of proteins, glutamic acid plays a principal role in neural activation. Glutamate is also responsible for the umami (savory) flavor of certain foods. In medicine, glutamate is used as a metabolic supplemnet in patients undergoing coronary surgery.   NCATS

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

(2s)-2-aminopentanedioic acid | 5-l-oxoproline | 5-oxo-2-pyrrolidinecarboxylic acid | 5-oxo-l-proline | 5-pyrrolidone-2-carboxylic acid | e620 | gamma glutamic acid | glu | glutamic acid | glutamic acid hydrochloride | l-glutamate | l-glutamic acid | l-glutamic acid hcl | l-glutaminic acid | muripsin | (s)-2-aminopentanedioic acid | (s)-glutamic acid

Organizations (9)

Research & Development (9)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (6)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (6)


 

Cervical Intraepithelial Neoplasia (Phase 2)

Colitis (Phase 1)

Gastroparesis ()

Heart Failure (Phase 3)

HIV Infections (Phase 1)

Neurotoxicity Syndromes (Phase 3)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial Organizations: 9

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue